FDA
approval
· 2019-10-07
FDA Approved: BUPRENORPHINE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
Summary
FDA approved a supplemental application for buprenorphine submitted by Hikma Pharmaceuticals USA Inc., authorizing changes to an approved generic product (ANDA …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for BUPRENORPHINE (BUPRENORPHINE)